🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to evaluate the safety, tolerability, and pharmacodynamics of migalas...
Status
Completed
Location
Multiple Locations
Start Date
2006-06-27
Trial ID
NCT00283959
Treatments Being Tested
To assess the efficacy and safety of larazotide acetate versus placebo for ...
Status
Terminated
Location
Research Site
Start Date
2019-05-29
Trial ID
NCT03569007
Treatments Being Tested
Study to evaluate the safety, tolerability, and pharmacodynamics of migalas...
Status
Completed
Location
Multiple Locations
Start Date
2006-09-07
Trial ID
NCT00304512
Treatments Being Tested
Study to evaluate the safety, tolerability, and pharmacodynamics of migalas...
Status
Completed
Location
Multiple Locations
Start Date
2006-05-09
Trial ID
NCT00283933
Treatments Being Tested
This was a long-term, open-label study of migalastat (123 milligrams \[mg\]...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-14
Trial ID
NCT01458119
Treatments Being Tested
This study was conducted to evaluate the efficacy of multiple doses of lara...
Status
Completed
Location
Study Site
Start Date
2007-08
Trial ID
NCT00492960
Treatments Being Tested
This program allows physicians to request permission from Amicus Therapeuti...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01476163
Treatments Being Tested
This is a long-term, Open-label Study to Evaluate the Safety, Pharmacodynam...
Status
Completed
Location
University of South Florida
Start Date
2019-10-11
Trial ID
NCT04049760
Treatments Being Tested
GR181413A/AT1001 (migalastat hydrochloride) is a low molecular weight imino...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09
Trial ID
NCT01853852
Treatments Being Tested
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2023-05-31
Trial ID
NCT05747534
Treatments Being Tested